Mortality trends in sickle cell patients.

Area of Science:

• Hematology
• Public Health
• Epidemiology

Background:

• Sickle cell disease disproportionately affects African Americans in the US, leading to frequent hospitalizations and high mortality.
• Historically, medical management focused on pain and hydroxyurea, with recent advancements in disease-modifying therapies.
• This study analyzes national trends in in-hospital mortality for sickle cell disease patients from 2000 to 2014.

Purpose of the Study:

• To examine nationwide trends in in-hospital mortality among sickle cell disease patients.
• To identify demographic and clinical factors associated with in-hospital mortality.
• To inform public health strategies for improving outcomes in sickle cell disease.

Main Methods:

• Analysis of hospitalization and in-hospital mortality data from the Agency of Healthcare Research and Quality database (2000-2014).
• Examination of mortality rates across US regions, hospital size, insurance status, comorbidities, and gender.
• Logistic regression analysis to determine patterns and odds ratios for in-hospital mortality.

Main Results:

• In-hospital mortality rates varied by US region, with the West showing the highest ratio (0.89%).
• Health insurance status was significantly associated with mortality (OR = 0.08).
• Comorbidities like atrial fibrillation (OR = 4.47) and hypertension (OR = 1.92) increased mortality risk, while smoking showed a protective effect (OR = 0.60).

Conclusions:

• Regional variations and health insurance status are key indicators of sickle cell disease's public health impact.
• Further granular data on state-level trends, comorbidities, and insurance status is needed for targeted interventions.
• These findings highlight the need for tailored public health approaches to mitigate sickle cell disease mortality.